Trial Profile

Phase I trial of bromopyruvate (PSL-001) in patients with primary and/or metastatic liver cancer.

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 18 Nov 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bromopyruvate (Primary)
Indications Liver cancer; Liver metastases
Focus Adverse reactions

Most Recent Events

26 Apr 2017 According to the PreScience media release, the company plans enrollment in this study in 2018.
25 Jul 2013 New trial record
24 Jul 2013 The US FDA has approved the IND application for phase I clinical evaluation of bromopyruvate and this trial is expected to be initiated in early 2014, according to a PreScience Labs media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com